Armo supports cancer research: donation renewed to the Piedmont Foundation for Cancer Research

In 2025, Armo renews its donation to the Piedmont Foundation for Cancer Research, providing concrete support to the activities of the IRCCS in Candiolo, recognized as one of Italy’s leading centers of excellence for cancer diagnosis, treatment, and research, and established as a national and international point of reference.

Over the years, the institute has become an essential hub for thousands of patients and healthcare professionals, building a strong reputation through high-profile collaborations.

For Armo, renewing its annual contribution means actively supporting this path of growth and innovation, helping to advance the development of new cancer therapies.

We firmly believe that charitable initiatives are a fundamental tool for fostering scientific progress, improving services, and strengthening the healthcare system for the benefit of patients. Continuing to support such a valuable organization is, for us, a commitment of enduring importance.